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OBJECTIVES METHODS 
CONCLUSIONS Propranolol is an amphipathic β-blocker drug
 used for its regulatory effects over blood
 pressure and anxiety levels. 
Recent studies have explored interactions of
 propranolol in various environments with
 respect to its pharmaceutical characteristics; i.e.
 cellular take-up, intracellular location, etc. 
We are interested in expanding the knowledge
 base of data and analysis on the relation
 between propranolol and β-, HP-β-, and γ
-cyclodextrins, with respect to solvent
 accessibility.  
The association constant of propranolol and β
-cyclodextrin and the Stern-Volmer quenching
 relationship with iodide were found by
 fluorescence spectroscopy.  
RESULTS 
BACKGROUND 
Propranolol hydrochloride is an amphipathic drug
 capable of interacting with cell membranes.  It has a
 MW of 295.81. 
Β-Cyclodextrin 
C42H20O35 
•MW of 1134.98 
• 6 glucopyranose units 
•forms inclusion complexes 
•Helps prevent quenching of included compounds 
Our observations show that the association constant of β-cyclodextrin
 and propranolol in the presence of potassium iodide is 152 M-1.
 Qualitative analysis shows the effects of quenching by potassium
 iodide, as with many salts. This is seen in the fluorescence spectra at
 0.04M KI and the Stern-Volmer plot. The Stern Volmer plot trendlines
 show the effects of adding increasingly higher concentrations of β
-cyclodextrin in order to enhance fluorescence of propranolol by
 sheltering it from the surrounding salt anions in solution. 
The association constant from a previous study was found to be 195
 M-1 by spectroscopic analysis and 239 M-1 by calorimetry. 
The results confirm that β-cyclodextrin increases fluorescence under
 quenching conditions. 
Inclusion Complex/Quenching Study – β-cyclodextrin 
Stock solutions of propranolol (1.0 x 10-3 M), β-cyclodextrin (16 mM),
 and Potassium Iodide (0.5 M) were created with 0.1M, pH=~7.0
 phosphate buffer as the solvent. Exactly 100µL of propranolol, a
 specified volume of 0.5M KI, and increasing volumes of β-CD were
 added to five 10mL volumetric flasks and diluted to achieve a final
 concentration of 10µM propranolol and 0mM, 1.5mM, 3mM, 6mM,
 and 12mM respective concentrations of β-CD. This was repeated for
 different specified final concentrations of KI, ranging from 0M to
 0.08M. Samples were then excited at 296nm in a Jobin Yvon Horiba
 FluorMax-3 Fluorimeter, and spectra were measured from
 300-450nm. 
Propranolol HCl 
Β-cyclodextrin 
Fluorescence is the emission lower energy light when excited by high
-energy light, usually ultraviolet. Only certain molecules can fluoresce,
 and each molecule has a unique excitation wavelength and emission
 wavelength(s). Fluorescence varies based on concentration of the
 fluorophore and presence of a quencher. 
Spectra, Intensity, and Stern-Volmer Plot 
The fluorescence intensity spectra for data collected in one
 concentration of the quencher shows the fluorescence
-enhancing effects of β-Cyclodextrin. In order to find the
 association constant of β-Cyclodextrin and propranolol in the
 presence of KI, the inverse of the difference between the
 intensity (sans iodide or β-CD) and the observed intensity at a
 given condition. This was done according to the equation
 below. The Stern-Volmer plot usually gives the association
 constant and “Stern-Volmer constants” but more data is
 needed. 
Fluorometric Analysis 
Cyclodextrins are used in a variety of ways, most often in
 industrial and pharmacoligical applications. They are cyclic
 oligosaccharides that range from 6 to 100+ units in size; β-
 and γ-cyclodextrins have 6 and 7 units, respectively. They
 are capable of inclusion complexes with various molecules,
 particularly due to their cone-shaped ring structure.
 Complexation can aid in a number of functions, such as
 enhancing fluorescence in the presence of a quencher. 
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As this is an ongoing study, more data will be pursued to increase
 accuracy of the presented analysis, with respect to β-cyclodextrin.
 Attempts will be made to analyze the association constants and
 quenching properties of the compounds in question across a variety of
 pH, temperature, and cyclodextrin derivatives. At the outset of the study,
 β-cyclodextrin was to be compared with 2-hydroxypropyl-β-cyclodextrin
 and γ-cyclodextrin inclusion complexes with propranolol. The study will
 aim to provide the same types of analysis for these two cyclodextrins. 2
-hydroxypropyl-β-cyclodextrin is a synthetically derived version of β
-cyclodextrin, with increased solubility characteristics because of its
 added polar substituent. 
After this study is completed, it would be beneficial to gain knowledge of
 the performance and location of the cyclodextrin derivatives in vivo. 
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